JERUSALEM and NEEDHAM, MA, June 26 /CNW/ - Oridion Systems Ltd. -
(SWX: ORIDN) Oridion Medical, the leading developer and manufacturer of
innovative capnography monitoring solutions, announced that it won the 2008
Manufacturers Partnership Award from IMDA, the association of medical
specialty sales and marketing companies. With this award, IMDA acknowledges
the Company's achievements in market development and support of its Specialty
distributors (part of the Oridion Distribution Network) to increase their
sales of Oridion capnography products.
The IMDA Manufacturers Partnership Award is given to the manufacturer
that offers exceptional clinical and sales support, communicates frequently
and openly with its Specialty distributors and responds promptly to questions,
suggestions or problems. IMDA also recognized Oridion's excellent marketing as
well as its active contribution to each dealer's increased revenues on the
The IMDA distributor members vote on this award based on their experience
with their manufacturers throughout the year. Tom Birmingham, IMDA Conference
Chairman, highlighted Oridion's approach to the market by its involvement and
support of major conferences and organizations like the APSF. "Oridion has
high-quality support people in place and it maintains great presence at
national shows," said Tom Birmingham. He added, "It also publishes excellent
literature, CEU packages and educational material for the customer."
Dominic Verrilli III, Vice President of Clinical Technology, Inc. (a
leading specialty distributor of medical products in the mid-western region of
the United States) enthusiastically endorsed Oridion at the IMDA meeting.
"Oridion provides exceptional clinical and sales supports. Their innovative
Oridion Knowledge Center provides on-line clinical and sales training that is
all-encompassing, simple to access and easy to use. The uniqueness of the
"Capnography on Tour" marketing program has given us a foothold into new
hospital areas and introduced us to new clinical champions for capnography
that will help us increase our sales. Many of the companies we represent have
solutions to future healthcare issues. In particular, Oridion's Microstream(R)
EtCO2 technology provides the solution to a pressing patient-safety need, that
is, the ability to safely monitor sedated patients!"
"Oridion is proud to have been recognized by IMDA," said Gerry Feldman,
President of Oridion Capnography. "Our company's strengths are not only great
products and customer support, but also the determination and creativity of
our sales and clinical teams to provide our distributors with the best tools
and programs to ensure growth in their sales. It aligns well with the
Company's commitment to taking stress, risk and cost out of health care by
improving patient safety with capnography."
Founded in 1978, IMDA is an association of sales, marketing and
distribution organizations focused on bringing innovative medical technologies
to market. For more information, visit http://www.imda.org
Oridion is the global leader of innovative capnography monitoring
solutions helping to improve patient safety, and its Microstream(R)
capnography technology has become the standard of care in ventilation
Next financial reporting:
August 18, 2008 Results Q2/Half Year 2008
November 10, 2008 Results Q3/Nine Months 2008
Oridion Systems Ltd. (http://www.oridion.com) is a global medical device
company specializing in patient safety monitoring. The Company operates
through wholly owned subsidiaries in the United States, Europe, and Israel.
Oridion develops proprietary medical devices and patient interfaces,
based on its patented Microstream(R) technologies, for the enhancement of
patient safety through the monitoring of the carbon dioxide (CO2) in a
patient's breath. These products provide effective, proven airway management
and are used in various clinical environments, including procedural sedation,
pain management, operating rooms, critical care units, post-anesthesia care
units, emergency medical services, transport, alternate care and other
settings where patients' ventilation may be compromised and at risk.
Certain statements made herein that are not historical are
forward-looking. The words "estimate" "project" "intend" "expect" "believe"
and similar expressions are intended to identify forward-looking statements.
These forward-looking statements involve known and unknown risks and
uncertainties. Many factors could cause the actual results, performance or
achievements of the Company to be materially different from any future
results, performance or achievements that may be expressed or implied by such
forward-looking statements, including, among others, our ability to maintain
profits, the market demands for our Capnography products, our ability to focus
our team on the Capnography business, changes in general economic and business
conditions, inability to maintain market acceptance to the Company's products,
inability to timely develop and introduce new technologies, products and
applications, rapid changes in the market for the Company's products, loss of
market share and pressure on prices resulting from competition, introduction
of competing products by other companies, inability to manage growth and
expansion, loss of key OEM partners, factors effecting OEM partners' position
in the market, inability to attract and retain qualified personnel, inability
to protect the Company's proprietary technology.
For further information:
For further information: Alan Adler, Chairman and Chief Executive
Officer; Walter Tabachnik, Chief Financial Officer; Elena Gerberg, Investor
Relations, e-mail: email@example.com, phone: +972-2-589-9159; address
Oridion Systems Ltd., P.O. Box 45025, 91450 Jerusalem, Israel